14 unknown. 14 Phase 2, 6 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Unknown 14 |
| Phase 1 | 6 | Unknown 6 |
| Phase 3 | 2 | Unknown 2 |
Follow Burns: new trials by email Literature Review of Burns trials Research Report on Burns
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s) PMS-101, Standard treatment - Burns, Burn Degree Second | Phase 1 / Phase 2 | Unknown | Primoris Therapeutics | 40 | 2025-01-01 | 2024-07-05 |
| Organ Protective Effect of Cetirizine In Patients With Severe Burns Cetirizine, Midazolam and Fentanyl - Burns | Phase 1 / Phase 2 | Unknown | Ruijin Hospital | 32 | 2024-01-23 | 2024-02-01 |
| MSCs for the Treatment of Burn Wounds Implantation of allogeneic MSCs on burn wounds - Burn Wound, Second- or Third-degree Burn | Phase 1 / Phase 2 | Unknown | Instituto Venezolano de Investigaciones Cientificas | 50 | 2021-06-30 | 2023-10-26 |
| Effects of Exercise During the Acute Phase of Burns Exercise, Standard of Care - Burns | Phase 2 | Unknown | Universiteit Antwerpen | 40 | 2020-05-04 | 2020-08-14 |
| Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds Autologous Engineered Skin Substitute, Split-Thickness Autograft (AG) - Thermal Injury, Deep Partial-Thickness Burn | Phase 2 | Unknown | Amarantus BioScience Holdings, Inc. | 10 | 2016-09-01 | 2016-08-31 |
| Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects Medical Collagen Membrane with MSC, Medical Collagen Membrane - Wounds, Diabetic Foot Ulcers | Phase 1 / Phase 2 | Unknown | South China Research Center for Stem Cell and Regenerative Medicine | 30 | 2016-05-01 | 2016-02-03 |
| Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs) ALLO-ASCs - Second- or Third-degree Burns | Phase 1 / Phase 2 | Unknown | A.A. Partners, LLC | 20 | 2015-03-25 | 2017-04-26 |
| The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes study of the efficacy of skin equivalent comprising living cells and skin biodegradable substrate for the treatment of skin lesions - Neurotrophic Ulcers, Burns | Phase 2 | Unknown | Ural State Medical University | 1 | 2014-02-01 | 2013-12-12 |
| Low Dose Doxycycline in the Treatment of Corneal Burn Doxycycline, Placebo - Eye Burns | Phase 2 / Phase 3 | Unknown | Sun Yat-sen University | 40 | 2013-09-01 | 2013-08-09 |
| Allogenic Stem Cell Therapy in Patients With Acute Burn human umbilical cord mesenchymal stem cells, human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells, Conventional therapy - Burns | Phase 1 / Phase 2 | Unknown | Shenzhen Beike Bio-Technology Co., Ltd. | 20 | 2011-07-01 | 2012-11-28 |
| Efficacy of R-Pdf/Gbb in Healing Wounds Caused by Third Degree Thermal and Electrical Burns R-Pdf/Gbb 0.01% gel - Burns, Electric Burns | Phase 2 | Unknown | American Scitech International | 120 | 2011-07-01 | 2011-07-20 |
| An Upgrading of the Resuscitative Patterns by Utilization of the Balanced Crystalloids and Synthetic Colloids and the Non-Invasive Hemodynamic Monitoring During Burn Shock LIDCO Lithium Dilution Cardiac Output, Standard Care - Burns, Shock | Phase 2 | Unknown | Faculty Hospital Kralovske Vinohrady | 20 | 2009-06-01 | 2009-06-05 |
| Use of Banana Leaf Dressing on Donor Site Wounds Banana Leaf Dressing, Hydrocolloid Dressing (DuoDERM CGF) - Burn | Phase 2 | Unknown | University of the Philippines | 10 | 2006-10-01 | 2020-04-24 |
| The Role of Amniotic Membrane Transplantation in Ocular Chemical Burns amniotic membrane transplantation - Eye Burns | Phase 2 / Phase 3 | Unknown | Shahid Beheshti University of Medical Sciences | 90 | 2006-07-01 | 2008-09-25 |
Eye Burns (2) · Neoplasm Metastasis (2) · Burns, Electric (1) · Diabetic Foot (1) · Insulin Resistance (1) · Muscular Atrophy (1) · Shock (1) · Wounds and Injuries (1)
Wounds and Injuries (13) · Pathological Conditions, Signs and Symptoms (4) · Nervous System Diseases (3) · Pathologic Processes (3) · Craniocerebral Trauma (2) · Eye Injuries (2) · Facial Injuries (2) · Neoplasms (2) · Neoplastic Processes (2) · Trauma, Nervous System (2) · Atrophy (1) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1)
Standard of Care (2) · Bandages, Hydrocolloid (1) · Cetirizine (1) · Chlortetracycline (1) · Doxycycline (1) · Exercise (1) · Fentanyl (1) · Gels (1) · Genes, sis (1) · Midazolam (1) · sulfadiazine, tetroxoprim drug combination (1)
A.A. Partners, LLC (1) · Amarantus BioScience Holdings, Inc. (1) · American Scitech International (1) · Faculty Hospital Kralovske Vinohrady (1) · Instituto Venezolano de Investigaciones Cientificas (1) · Primoris Therapeutics (1) · Ruijin Hospital (1) · Shahid Beheshti University of Medical Sciences (1) · Shenzhen Beike Bio-Technology Co., Ltd. (1) · South China Research Center for Stem Cell and Regenerative Medicine (1) · Sun Yat-sen University (1) · Universiteit Antwerpen (1) · University of the Philippines (1) · Ural State Medical University (1)
China (3) · United States (2) · Australia (1) · Belgium (1) · Czechia (1) · Iran (1) · Philippines (1) · Russia (1) · Ukraine (1) · Venezuela (1)
Alireza Baradaran Raffiee, MD (1) · Anatoliy V. Voronin (1) · Dan Liang, MD (1) · Georgiy P. Kozynets, MD, PhD, DSc (1) · Jeane Azarcon, MD (1) · Joanneke Joanneke, Dr (1) · Michael Peck, MD (1) · Nani E Mansour, MD (1) · Oleg G Makeev, MD (1) · Olga L Wittig, MSc (1) · Ratna Grewal, MD (1) · Ulrike Van Daele (1) · Yan Liu (1)
PMID 15103422, PMID 16483293, PMID 17019126, PMID 35953455, PMID 36843581